FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,392 | +1016.1% | 10,899 | +729.5% | 0.00% | – |
Q2 2023 | $4,336 | -99.2% | 1,314 | -99.3% | 0.00% | – |
Q1 2023 | $543,000 | +40271.7% | 190,269 | +3.0% | 0.00% | – |
Q4 2022 | $1,345 | -99.9% | 184,686 | -5.8% | 0.00% | – |
Q3 2022 | $1,585,000 | +63.2% | 195,960 | -1.1% | 0.00% | – |
Q2 2022 | $971,000 | -79.5% | 198,115 | -1.1% | 0.00% | -100.0% |
Q1 2022 | $4,739,000 | +32.0% | 200,386 | -1.2% | 0.00% | – |
Q4 2021 | $3,589,000 | -26.8% | 202,873 | +16.8% | 0.00% | -100.0% |
Q3 2021 | $4,901,000 | +153.4% | 173,727 | -5.9% | 0.00% | – |
Q2 2021 | $1,934,000 | -38.2% | 184,572 | -30.5% | 0.00% | – |
Q1 2021 | $3,127,000 | +571.0% | 265,505 | +567.1% | 0.00% | – |
Q4 2020 | $466,000 | +1036.6% | 39,800 | +646.0% | 0.00% | – |
Q3 2020 | $41,000 | -52.9% | 5,335 | +12.3% | 0.00% | – |
Q2 2020 | $87,000 | -65.6% | 4,750 | -77.6% | 0.00% | – |
Q1 2020 | $253,000 | +155.6% | 21,176 | +258.2% | 0.00% | – |
Q4 2019 | $99,000 | +890.0% | 5,912 | +297.3% | 0.00% | – |
Q3 2019 | $10,000 | – | 1,488 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |